1198444
1206379
1206367
H3D Vision & Mission
Vision: To be the leading organisation for integrated drug discovery and development on the African continent Mission: Discover and develop innovative, life saving medicines For African patients Through excellence in interdisciplinary,...
R&D Environment
UCT offers a truly integrated environment for translational research in communicable and non communicable diseases afflicting people in Africa. It has both the infrastructure as well as numerous groups working on pre-clinical and clinical research...
H3D Facilities
Facilities H3D has state of the art laboratory equipment and access to modern instrumentation housed in the Department of Chemistry, the Department of Clinical Pharmacology and the Institute of Infectious Disease and Molecular Medicine (IDM) at UCT...
Home > Home

News

Sunday, 19 May 2019
Kelly Chibale in the Financial Times

The US Financial Times recently featured Kelly Chibale as an Innovator in Drug Discovery in Africa

 

Publication Date:
Fri, 15 Mar 2019 - 14:00
GOLD MEDALLIST CHIBALE WARNS OF AFRICAN 'BRAIN DRAIN'

UCT’S H3D DIRECTOR, KELLY CHIBALE, WINS SACI GOLD MEDAL AWARD AND IS HONOURED BY ASTMH; WARNS ABOUT THE BRAIN DRAIN OF AFRICAN SCIENTISTS

Professor Kelly Chibale, founder and director of the Drug Discovery and Development Centre, H3D, at the University of Cape Town (UCT), has been awarded the prestigious Gold Medal for 2018 by the South African Chemical Institute (SACI) and honoured by the American Society of Tropical Medicine and Hygiene (ASTMH) with the 2018 Commemorative Fund Lecture.  

Publication Date:
Wed, 24 Oct 2018 - 14:00
GRAND CHALLENGES MEETING

Prof Kelly Chibale participated in the Bill and Melinda Gates Foundation's Grand Challenges meeting held in Berlin, Germany from 15-18 October 2018 and gave a Spotlight talk.  

Publication Date:
Wed, 24 Oct 2018 - 14:00
PRACTICAL ASPECTS OF DRUG DISCOVERY
Learn about the theoretical, practical and organisational aspects of small molecule and natural product drug discovery.
Publication Date:
Fri, 29 Jun 2018 - 14:00

Pages